Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Significant Financial Services Contract Win

3 Jan 2018 07:00

RNS Number : 7665A
WANdisco Plc
03 January 2018
 

3 January 2018 

WANdisco plc

("WANdisco," or the "Company")

LEI: 213800Y1A75RSC698O04

 

SIGNIFICANT FINANCIAL SERVICES CONTRACT WIN

 

Record $4.3 million contract secured through IBM OEM partnership

 

WANdisco (LSE: WAND), the live data company, today announces a record contract win with one of the world's leading financial institutions (the "Client") to deploy the Company's patented live data platform, WANdisco Fusion ("Fusion"), rebranded as IBM Big Replicate, directly to the Client. The agreement, which is the second multi-million dollar contract in the financial services sector secured by WANdisco during 2017, will be delivered through the Company's IBM OEM partnership and is valued at $4.32 million in royalties to be paid to WANdisco.

 

WANdisco Fusion was selected after an extensive period of testing by the Client and was deemed to be the only enterprise-grade solution able to support critical Cloud and Big Data applications. Fusion will be used to enable the Client to move critical live data seamlessly between both primary and disaster recovery sites and the Cloud whilst ensuring the data is always available.

 

The Company continues to demonstrate that WANdisco Fusion is the only solution that can enable organisations to seamlessly move large volumes of live data with consistent and continuous availability whilst meeting regulatory requirements. WANdisco's patented technology ensures our customers are able to multiply the impact of their IT investment to support exponential data growth without growing the IT budget.

 

David Richards, Chief Executive Officer and Interim Chairman of WANdisco, commented:

 

"We are delighted to have secured this record contract win, which further endorses our strong credentials within the financial services sector as well as providing additional validation that our IBM partnership is successfully delivering our solutions into very large enterprise customers.

 

"As a result of Fusion's unique capability, we have developed a significant new business pipeline across multiple industry verticals not only through our partnership with IBM, but via our other channel partners, as we maximise our routes to market."

 

 

For further information, please contact:

 

WANdisco plc

via Vigo Communications

David Richards, Chief Executive Officer and Interim Chairman

 

Erik Miller, Chief Financial Officer

 

 

 

Vigo Communications

+44 (0)207 830 9700

Jeremy Garcia / Fiona Henson / Antonia Pollock

www.vigocomms.com

 

 

 

Stifel (Joint Broker and Nomad)

+44 (0)207 710 7600

 Fred Walsh / Neil Shah / Ben Maddison / Rajpal Padam

 

 

 

Peel Hunt (Joint Broker)

Edward Knight / Nick Prowting

+44 (0)207 418 8900

 

 

About WANdisco

WANdisco is shaping the future of data infrastructure with its groundbreaking Live Data platform, enabling companies to put all their data to work for the business - all the time, at any scale.

 

WANdisco makes data always available, always accurate, and always protected, delivering hyperscale economics to support exponential data growth with the same IT budget. With significant OEM relationships with IBM and Dell EMC and go-to-market partnerships with Amazon Web Services, Cisco, Microsoft Azure, Google Cloud, Hewlett Packard Enterprise, Oracle and other industry titans - as well as hundreds of customers among the Global 2000 - WANdisco is igniting a Live Data movement worldwide.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTQLLFBVFFZBBB
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.